Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: II. Role of human ZIP9 in testosterone-induced prostate and breast cancer cell apoptosis

Endocrinology (United States)

Volumn 155, Issue 11, 2014, Pages 4250-4265

  Thomas, Peter ^a   Pang, Yefei ^a   Dong, Jing ^a   Berg, A Håkan ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b ÖREBRO UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIONE; BICALUTAMIDE; CASPASE 3; CYTOCHROME C; ESTRADIOL; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROCORTISONE; HYDROXYFLUTAMIDE; MIBOLERONE; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROTEIN BAX; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TESTOSTERONE; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZIP 9 ZINC TRANSPORTER; CATION TRANSPORT PROTEIN; MEMBRANE PROTEIN; SLC39A9 PROTEIN, HUMAN; ZINC;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN; BREAST CANCER; CANCER CELL; CELL FRACTIONATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; COLON; COMPETITIVE BINDING ASSAY; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HEART; HORMONE BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; JURKAT CELL LINE; KIDNEY; LIGAND BINDING; LIVER; LNCAP CELL LINE; MALE; MEMBRANE BINDING; MICROSOME; NICK END LABELING; OVARY; PANCREAS; PROSTATE; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCATCHARD PLOT; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STABLE TRANSFECTION; TESTIS; TRANSIENT TRANSFECTION; TUMOR BIOPSY; UPREGULATION; UTERUS; WESTERN BLOTTING; ADULT; BREAST TUMOR; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; MOLECULAR CLONING; MULTIGENE FAMILY; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL CULTURE;

ADULT; APOPTOSIS; BREAST NEOPLASMS; CATION TRANSPORT PROTEINS; CLONING, MOLECULAR; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MULTIGENE FAMILY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TESTOSTERONE; TUMOR CELLS, CULTURED; ZINC;

EID: 84908032549     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1201     Document Type: Article

References (64)

1. Revelli A, Massobrio M, Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev. 1998;19:3-17.
2. Thomas P. Rapid steroid hormone actions initiated at the cell surface and the receptors that mediate them with an emphasis on recent progress in fish models. Gen Comp Endocrinol. 2012;175:367-383.
3. Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov. 2004;3:27-41.
4. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW. Rβ has nongenomic action in caveolae. Mol Endocrinol. 2002;16:938-946.
5. Yang X, Guo Z, Sun F, et al. Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells. J Biol Chem. 2011;286:36152-36160.
6. Boonyaratanakornkit V, Scott MP, Ribon V, et al. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol. 2007;21:359-375.
7. Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β. Proc Natl Acad Sci USA. 2000;97:11603-11608.
8. Frye CA, Sumida K, Lydon JP, O'Malley BW, Pfaff DW. Mid-aged and aged wild-type and progestin receptor knockout (PRKO) mice demonstrate rapid progesterone and 3α, 5α-THP-facilitiated lordosis. Psychopharmacology. 2006;185:423-432.
9. Benten WP, Lieberherr M, Giese G, et al. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 1999;13:123-133.
10. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA. 2003;100:2231-2236.
11. Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA. 2003;100:2237-2242.
12. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of a membrane estrogen receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146:624-632.
13. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625-1630.
14. Rahman F, Christian HC. Non-classical actions of testosterone: an update. Trends Endocrinol Metab. 2008;18:371-378.
15. Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol. 2008;29:169-181.
16. Machelon V, Nomé F, Tesarik J. Nongenomic effects of androstene-dione on human granulosa luteinizing cells. J Clin Endocrinol Metab. 1998;83:263-269.
17. Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Gα(i2,3). J Biol Chem. 2002;277:21379-21388.
18. Braun AM, Thomas P. Androgens inhibit estradiol-17β synthesis in Atlantic croaker (Micropogonias undulatus) ovaries by a nongenomic mechanism initiated at the cell surface. Biol Reprod. 2003;69:1642-1650.
19. Sun YH, Gao X, Tang YJ, Xu C-L, Wang LH. Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J Androl. 2006;27:671-678.
20. Armen TA, Gay CV. Simultaneous detection and functional response of testosterone and estradiol receptors in osteoblast plasma membranes. J Cell Biochem. 2000;79:620-627.
21. Lieberherr M, Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem. 1994;269:7217-7223.
22. Benten WP, Lieberherr M, Stamm O, Wrehlke C, Guo Z, Wunderlich F. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell. 1999;10:3113-3123.
23. Leung GP, Cheng-Chew SB, Wong PY. Nongenomic effect of testosterone on chloride secretion in cultured rat efferent duct epithelia. Am J Physiol Cell Physiol. 2001;280:C1160-C1167.
24. Hatzoglou A, Kampa M, Kogia C, et al. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J Clin Endocrinol Metab. 2005;90:893-903.
25. Guo Z, Benten WP, Krücken J, Wunderlich F. Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptorfree macrophages. J Biol Chem. 2002;277:29600-29607.
26. Kelder J, Azevedo R, Pang Y, de Vlieg J, Dong J, Thomas P. Comparison between steroid binding to membrane progesterone receptor α (mPRα) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRα-specific agonists. Steroids. 2010;75:314-322.
27. Bologa CG, Revankar CM, Young SM, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006;2:207-212.
28. Cousins RJ, Liuzzi JP, Lichten LA. Mammalian zinc transport, trafficking, and signals. J Biol Chem. 2006;281:24085-24089.
29. Solomons NW. Update on zinc biology. Ann Nutr Metab. 2013;62:8-17.
30. Jackson KA, Valentine RA, Coneyworth LJ, Mathers JC, Ford D. Mechanisms of mammalian zinc-regulated gene expression. Biochem Soc Trans. 2008;36:1262-1266.
31. Vallee BL, Auld DS. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry. 1990;29:5647-5659.
32. Formigari A, Irato P, Santon A. Zinc, antioxidant systems and metallothionein in metal-mediated apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C. 2007;146:443-459.
33. Hasse H, Rink L. Functional significance of zinc-related signaling pathways in immune cells. Ann Rev Nutr. 2009;29:133-152.
34. Jeong J, Eide DJ. The SLC39 family of zinc transporters. Mol Aps Med. 2013;34:612-619.
35. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (SLC30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA. 2007;104:17040-17045.
36. Franklin RB, Feng P, Milon B, et al. hZIP1 zinc uptake transporter turnover down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005;4:32.
37. Fukada T, Kambe T. Molecular and genetic features of zinc transporters in physiology and pathogenesis. Metallomics. 2011;3:662-674.
38. Matsuura W, Yamazaki T, Yamaguchi-Iwai Y, et al. SLC39A9 (ZIP9) regulates zinc homeostasis in the secretory pathway: characterization of the ZIP subfamily I protein in vertebrate cells. Biosci Biotechnol Biochem. 2009;73:1142-1148.
39. Taniguchi M, Fukunaka A, Hagihara M, et al. Essential role of the zinc transporter ZIP9/SLC39A9 in regulating the activations of Akt and Erk in B-cell receptor signaling pathway in DT40 cells. PLoS One. 2013;8(3):e58022.
40. Papadopoulou N, Papakonstanti EA, Kallergi G, et al. Membrane androgen receptor activation in prostate and breast tumor cells: molecular signaling and clinical impact. IUBMB Life. 2009;61:56-61.
41. Pang Y, Dong J, Thomas P. Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and ε (mPRδ and mPRε) and mPRδ involvement in neurosteroid inhibition of apoptosis. Endocrinology. 2013;154:283-295.
42. Filardo E, Quinn J, Pang Y, et al. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology. 2007;148:3236-3245.
43. Braun AM, Thomas P. Biochemical characterization of a membrane androgen receptor in the ovary of the Atlantic croaker (Micropogonias undulatus). Biol Reprod. 2004;71:146-155.
44. Merten KE, Jiang Y, Kang YJ. Zinc inhibits doxorubicin-activated calcineurin signal transduction pathway in H9c2 embryonic rat cardiac cells. Exp Biol Med (Maywood). 2007;232:682-689.
45. el-Tanani MK, Green CD. Oestrogen-induced genes, pLIV-1 and pS2, respond divergently to other steroid hormones in MCF-7 cells. Mol Cell Endocrinol. 1995;111:75-81.
46. Nakashima AS, Oddo S, Laferla FM, Dyck RH. Experience-dependent regulation of vesicular zinc in male and female 3xTg-Ad mice. Neurobiol Aging. 2010;31:605-613.
47. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA. 2002;99:7705-7710.
48. Beltramini M, Zambenedetti P, Wittkowski W, Zatta P. Effects of steroid hormones on the Zn, Cu and MTI/II levels in the mouse brain. Brain Res. 2004;1013:134-141.
49. Song MK, Kim YY, Heng MCY, Adham NF, Ament ME. Prostaglandin interacts with steroid sex hormones in the regulation of intestinal zinc transport. Comp Biochem Physiol. 1992;101A:477-481.
50. Costello LC, Liu Y, Zou J, Franklin RB. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem. 1999;274:17499-17504.
51. Taylor KM, Morgan HE, Smart K, et al. The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Mol Med. 2007;13:396-406.
52. Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 2011;351:41-58.
53. Pietsch EC, Sykes SM, McMahon SB, Murphy ME. The p53 family and programmed cell death. Oncogene. 2008;27:6507-6521.
54. Sinha K, Das J, Pal PB, Sil PC. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol. 2013;87:1157-1180.
55. Feng P, Li TL, Guan ZX, Franklin RB, Costello LC. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate. 2002;52:311-318.
56. Feng P, Li T, Guan Z, Franklin RB, Costello LC. The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol Cancer. 2008;7:25.
57. Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, et al. Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/ NF-κB activity and induces apopototic responses via Bad, FasL and caspase -3 in DUI145 prostate cancer cells. Mol Cancer. 2008;7:88.
58. Kampa M, Nifli AP, Charalampopoulos I, et al. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp Cell Res. 2005;307:41-51.
59. Uhlén M, Björling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4:1920-1932.
60. Franz M-C, Anderle P, Bürzle M, Suzuki Y, et al. Zinc transporters in prostate cancer. Mol Aps Med. 2013;34:735-741.
61. Grattan BJ, Freake HC. Zinc and cancer: implications for LIV-1 in breast cancer. Nutrients. 2012;4:648-675.
62. Hanby AM. The pathology of breast cancer and the role of the histopathology laboratory. Clin Oncol (R Coll Radiol). 2005;17:234-239.
63. Berges RR, Vukanovic J, Epstein JI, et al. Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Canc Res. 1995;1:473-480.
64. Berg AH, Rice CD, Rahman Md S, Dong J, Thomas P. Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: I. Discovery in female Atlantic croaker and evidence ZIP9 mediates testosterone-induced apoptosis of ovarian follicle cells. Endocrinology. 2014;155:4237-4249.